Teva settles Sensipar patent dispute with Amgen

04-01-2019

Teva settles Sensipar patent dispute with Amgen

clu / iStockphoto.com

Teva Pharmaceuticals has announced that it has resolved a dispute with Amgen over Teva’s generic cinacalcet HCI product.


Teva Pharmaceuticals, Sensipar, Amgen, patent infringement, settlement, Cinacalcet HCI

LSIPR